To our valued customers,

We have exciting news to share!  ChanTest, the world's most trusted ion channel services company, has acquired Applied Cell Sciences (ACS), a leader in GPCR (G-protein coupled receptors) products and services.  We look forward to continuing to offer the very best in quality ion channel and GPCR services, cell lines, and reagents to meet your drug discovery and development needs. 

What does this news mean for you? 

We can serve your drug discovery and development needs even better with integrated, high-throughput and GLP ion channel-GPCR services, cell lines, and reagents that cover nearly half of the known drugable genome.

ACS' scale-up capabilities will make management of the ChanTest ion channel library more efficient, while ChanTest's high-throughput GPCR readout capabilities will increase GPCR capacities at ACS.

Your primary contact, whether at ACS or ChanTest, remains the same.  We will work with our colleagues across the company to meet all of your ion channel and GPCR needs.  Of course, you can still rely on all of the scientists that you've already come to know and trust.  Catalog numbers and pricing remain unchanged.

ChanTest is in Cleveland, Ohio 216.332.1665  www.chantest.com

The ACS group is in Rockville, Maryland 240.453.6331 www.appliedcellsci.com

To learn more about our ion channel/GPCR products and services, email: NewChantest@chantest.com or inquiries@appliedcellsci.com.

If you have any questions, feedback, or concerns, please do not hesitate to contact either one of us.

Sincerely,

Arthur (Buzz) Brown, MD, Ph.D. , President and CEO   

Jesse Baumgold, Ph.D.,  VP of Business Development & Product Strategy